BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Molecular Templates Announces Executive Leadership Changes - August 02, 2023

  Molecular Templates, Inc. announced executive management changes to implement its next phase of development.

  August 2, 2023

   · 

  6 min read
• Lung Diagnostic Assessment Program Outreach Clinic in Napanee, ON Expedites Assessment and Diagnosis for Patients with Lung Cancer

  Just over two years since challenging Ontario-based innovators to identify solutions to help enhance the lung cancer patient journey by improving timeliness of care, Merck Canada is proud to share new data from the winning team at Kingston Health Sciences Centre.

  August 2, 2023

   · 

  6 min read
• BioMidwest

  Sentinel Medical Technologies Addresses IAP Transducer Shortage With Traumaguard

  In the face of the ongoing supply issues affecting Intra-Abdominal Pressure transducer kits, Sentinel Medical Technologies is stepping up to ensure that patient care remains uncompromised.

  August 2, 2023

   · 

  3 min read
• Business

  Deciphera Pharmaceuticals to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast on August 9, 2023

  Deciphera Pharmaceuticals, Inc. today announced that it will report its second quarter 2023 financial results on Wednesday, August 9, 2023.

  August 2, 2023

   · 

  1 min read
• Business

  GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2023

  GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today reported its financial results and highlights for the second quarter ended June 30, 2023.

  August 2, 2023

   · 

  8 min read
• Biotech Bay

  CareDx’s HeartCare Multimodality Service Receives Medicare Coverage for Heart Transplant Surveillance

  CareDx, Inc. announced Medicare coverage for HeartCare, a multimodality testing service that includes both AlloMap® Heart and AlloSure® Heart, in a given patient encounter, for heart transplant surveillance.

  August 2, 2023

   · 

  6 min read
• Business

  Bausch + Lomb Announces Second-Quarter 2023 Results and Raises Full-Year 2023 Revenue Outlook

  Bausch + Lomb Corporation, (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its second-quarter 2023 financial results.

  August 2, 2023

   · 

  39 min read
• Business

  Amarin Reports Second Quarter 2023 Financial Results

  Amarin Corporation plc (NASDAQ:AMRN) today announced financial results for the quarter ended June 30, 2023 and provided an update on company operations.

  August 2, 2023

   · 

  15 min read
• Business

  Nautilus Biotechnology Reports Second Quarter 2023 Financial Results

  Nautilus Biotechnology, Inc. today reported financial results for the second quarter ended June 30, 2023.

  August 2, 2023

   · 

  8 min read
• Business

  Zevra Therapeutics to Report Second Quarter 2023 Results on August 14, 2023

  Zevra Therapeutics, Inc. has announced that it will host a conference call and live audio webcast on Monday, August 14, 2023, at 8:30 a.m. ET, to review its corporate and financial results for the second quarter of 2023.

  August 2, 2023

   · 

  2 min read